MX2016008305A - Combinaciones de peptidos y usos de los mismos en tratar alergia al acaro del polvo. - Google Patents
Combinaciones de peptidos y usos de los mismos en tratar alergia al acaro del polvo.Info
- Publication number
- MX2016008305A MX2016008305A MX2016008305A MX2016008305A MX2016008305A MX 2016008305 A MX2016008305 A MX 2016008305A MX 2016008305 A MX2016008305 A MX 2016008305A MX 2016008305 A MX2016008305 A MX 2016008305A MX 2016008305 A MX2016008305 A MX 2016008305A
- Authority
- MX
- Mexico
- Prior art keywords
- dust mite
- der
- peptide combinations
- peptides
- mite allergy
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 239000000428 dust Substances 0.000 title abstract 3
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 208000026935 allergic disease Diseases 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 239000013566 allergen Substances 0.000 abstract 2
- 108700028369 Alleles Proteins 0.000 abstract 1
- 108010055622 Dermatophagoides farinae antigen f 1 Proteins 0.000 abstract 1
- 108010082995 Dermatophagoides farinae antigen f 2 Proteins 0.000 abstract 1
- 108010061629 Dermatophagoides pteronyssinus antigen p 1 Proteins 0.000 abstract 1
- 108010061608 Dermatophagoides pteronyssinus antigen p 2 Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se relaciona a combinaciones de péptidos o variantes de los mismos derivados de una porción de una secuencia de amino de un alérgeno de ácaro del polvo doméstico, por ejemplo los alérgenos Der p 1, Der f 1, Der p 2 y/o Der f 2. Tales péptidos comprenden al menos un epítopo de célula T y un número elevado significativo de pacientes en una población mundial tendrán alelos HLA con el potencial de ligar los péptidos de las combinaciones de péptidos. La invención también se relaciona al uso de tales combinaciones de péptidos en aliviar una respuesta inmunitaria causada por un ácaro del polvo.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361919925P | 2013-12-23 | 2013-12-23 | |
| US201462012690P | 2014-06-16 | 2014-06-16 | |
| PCT/US2014/072228 WO2015100360A1 (en) | 2013-12-23 | 2014-12-23 | Peptide combinations and uses thereof in treating dust mite allergy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016008305A true MX2016008305A (es) | 2017-01-11 |
Family
ID=52293308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016008305A MX2016008305A (es) | 2013-12-23 | 2014-12-23 | Combinaciones de peptidos y usos de los mismos en tratar alergia al acaro del polvo. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10059751B2 (es) |
| EP (1) | EP3086806B1 (es) |
| JP (1) | JP2017507906A (es) |
| KR (1) | KR20160096206A (es) |
| CN (1) | CN105848677B (es) |
| AU (1) | AU2014369866A1 (es) |
| BR (1) | BR112016011930A2 (es) |
| CA (1) | CA2933552A1 (es) |
| EA (1) | EA201691306A1 (es) |
| MX (1) | MX2016008305A (es) |
| SG (1) | SG11201604892YA (es) |
| WO (1) | WO2015100360A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011260233C1 (en) * | 2010-06-03 | 2015-04-16 | Alk-Abello A/S | Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof |
| US11013781B2 (en) | 2015-07-01 | 2021-05-25 | Alk-Abelló As | Peptide combinations and uses thereof for treating grass allergy |
| EP3383427A4 (en) * | 2015-12-04 | 2019-11-27 | Mayo Foundation for Medical Education and Research | METHOD AND VACCINES FOR INDUCTION OF IMMUNE REACTIONS TO SEVERAL DIFFERENT MHC MOLECULES |
| US10556936B2 (en) | 2016-05-27 | 2020-02-11 | Alk Abelló | Immunogenic proteins and fragments thereof from allergenic mites |
| CN108265059B (zh) | 2016-12-31 | 2021-01-05 | 江苏众红生物工程创药研究院有限公司 | 一种重组粉尘螨2类变应原蛋白及其制备方法与应用 |
| CN107338261B (zh) * | 2017-07-17 | 2023-04-07 | 海南大学 | 热带无爪螨重组变应原Blot5-21、其制备方法及过敏小鼠模型的建立 |
| CN119367552A (zh) * | 2019-03-14 | 2025-01-28 | 恩根尼公司 | 壳聚糖-核酸纳米颗粒的可逆包衣以及其使用方法 |
| CN113125753B (zh) * | 2021-04-16 | 2022-07-26 | 杭州浙大迪迅生物基因工程有限公司 | 一种用于检测尘螨组分特异性抗体的试剂盒 |
| KR20240140698A (ko) | 2023-03-17 | 2024-09-24 | 가톨릭대학교 산학협력단 | 집먼지진드기 항원 및 히알루론산 하이드로젤을 유효성분으로 포함하는 알레르기 질환 면역 치료용 조성물 |
| GB202409214D0 (en) * | 2024-06-26 | 2024-08-07 | Univ Birmingham | tolerogenic peptides |
| CN120559260A (zh) * | 2025-07-30 | 2025-08-29 | 无锡市人民医院 | 过敏原Blo t 24在尘螨过敏原组分检测中的应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5194596A (en) * | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
| US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
| AU682658B2 (en) | 1991-10-16 | 1997-10-16 | Merck Patent Gmbh | Recombitope peptides |
| WO1994024281A1 (en) | 1993-04-14 | 1994-10-27 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| US7288256B1 (en) * | 1991-10-16 | 2007-10-30 | Merck Patent Gmbh | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| US5820862A (en) * | 1994-04-14 | 1998-10-13 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| AU717187B2 (en) | 1994-04-14 | 2000-03-16 | Merck Patent Gmbh | Pharmaceutical peptide formulations for treatment of dust mite allergy |
| JP2001231563A (ja) * | 2000-02-18 | 2001-08-28 | Asahi Breweries Ltd | 改変したダニアレルゲン(システイン変異体)及びその製造方法 |
| JP2007511318A (ja) | 2003-11-18 | 2007-05-10 | ナノ パス テクノロジーズ リミテッド | 改良された挿入システム及びマイクロニードルを摺動させるための方法 |
| US8007466B2 (en) | 2004-11-18 | 2011-08-30 | Nanopass Technologies Ltd. | System and method for delivering fluid into flexible biological barrier |
| JP2010512170A (ja) | 2005-12-08 | 2010-04-22 | ナノパス テクノロジーズ エルティディ. | 薬剤投与器用マイクロ・ニードル・アダプタ |
| PL2059256T3 (pl) * | 2006-08-11 | 2017-02-28 | Life Sciences Research Partners Vzw | Immunogenne peptydy i ich zastosowanie w zaburzeniach immunologicznych |
| EP2083856B1 (en) * | 2007-08-15 | 2010-09-29 | Circassia Limited | Peptides for desensibilization against allergens |
| JP5705113B2 (ja) | 2008-08-15 | 2015-04-22 | サーカッシア リミテッド | Il−10産生の刺激のためのアレルゲン由来のt細胞抗原 |
| DK2717910T3 (en) | 2011-06-09 | 2019-04-15 | Biomay Ag | PEPTIDE CARRIER FUSION PROTEINS LIKE ALLERGY VACCINES |
| WO2013061290A1 (en) | 2011-10-26 | 2013-05-02 | Nanopass Technologies Ltd. | Microneedle intradermal drug delivery device with auto-disable functionality |
| JP2015509487A (ja) * | 2012-02-07 | 2015-03-30 | ラ ホーヤ インスティテュート フォー アレルギー アンド イムノロジーLa Jolla Institute For Allergy And Immunology | アレルゲンタンパク質由来のエピトープ並びに免疫応答モジュレーションのための方法及び使用 |
| IN2014MN01513A (es) | 2012-02-07 | 2015-09-11 | Jolla Inst Allergy Immunolog | |
| US20130302338A1 (en) | 2012-05-14 | 2013-11-14 | Promd Biotech. Co., Ltd. | Dermatophagoid pteronyssinus (der p1) antigen epitope and anti-der p1 antibody |
| US20140350514A1 (en) | 2013-05-22 | 2014-11-27 | Nanopass Technologies Ltd. | Systems and methods for intradermal delivery of therapeutics using microneedles |
-
2014
- 2014-12-23 MX MX2016008305A patent/MX2016008305A/es unknown
- 2014-12-23 WO PCT/US2014/072228 patent/WO2015100360A1/en not_active Ceased
- 2014-12-23 AU AU2014369866A patent/AU2014369866A1/en not_active Abandoned
- 2014-12-23 SG SG11201604892YA patent/SG11201604892YA/en unknown
- 2014-12-23 EP EP14824746.3A patent/EP3086806B1/en active Active
- 2014-12-23 CA CA2933552A patent/CA2933552A1/en not_active Abandoned
- 2014-12-23 CN CN201480070484.5A patent/CN105848677B/zh active Active
- 2014-12-23 EA EA201691306A patent/EA201691306A1/ru unknown
- 2014-12-23 US US15/021,775 patent/US10059751B2/en active Active
- 2014-12-23 JP JP2016543009A patent/JP2017507906A/ja active Pending
- 2014-12-23 BR BR112016011930A patent/BR112016011930A2/pt not_active Application Discontinuation
- 2014-12-23 KR KR1020167020337A patent/KR20160096206A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| BR112016011930A2 (pt) | 2017-09-26 |
| CA2933552A1 (en) | 2015-07-02 |
| AU2014369866A1 (en) | 2016-06-30 |
| EP3086806A1 (en) | 2016-11-02 |
| EA201691306A1 (ru) | 2016-10-31 |
| WO2015100360A1 (en) | 2015-07-02 |
| US20160251403A1 (en) | 2016-09-01 |
| KR20160096206A (ko) | 2016-08-12 |
| EP3086806B1 (en) | 2019-12-11 |
| US10059751B2 (en) | 2018-08-28 |
| CN105848677A (zh) | 2016-08-10 |
| CN105848677B (zh) | 2020-01-31 |
| JP2017507906A (ja) | 2017-03-23 |
| SG11201604892YA (en) | 2016-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016008305A (es) | Combinaciones de peptidos y usos de los mismos en tratar alergia al acaro del polvo. | |
| MY197669A (en) | Chimeric receptors and methods of use thereof | |
| ZA201805295B (en) | Methods for enhancing efficacy of a vaccine by administering an il¿4r antagonist | |
| WO2014113490A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| TN2017000085A1 (en) | Polypeptide having a polyester degrading activity and uses thereof | |
| TN2018000337A1 (en) | Chimeric receptors to flt3 and methods of use thereof | |
| NZ715038A (en) | T cell receptors | |
| MX2021012014A (es) | Vectores del factor viii del virus adeno-asociado. | |
| MX373035B (es) | Trastornos neurodegenerativos. | |
| MX364952B (es) | Particula tipo virus que comprende antigeno de muerte celular programada 1 o antigeno de ligando de muerte celular programada 1. | |
| MX2012002357A (es) | Composiciones que inducen la ayuda de las celulas t. | |
| MX393988B (es) | Variantes de interferon a2b. | |
| MX385670B (es) | Anticuerpos anti-garp-tgf-b. | |
| EA201891460A1 (ru) | Композиция дендритных клеток | |
| MX2018014716A (es) | Anticuerpos anti-tnfrsf25. | |
| MX2014008146A (es) | Constructos de mhc parciales y metodos de uso. | |
| GB201206070D0 (en) | Clostridium difficile antigens | |
| MX2011008179A (es) | Peptidos para vacuna. | |
| EP2552462A4 (en) | CCN3 THERAPEUTIC PEPTIDES AND THEIR ANALOGS | |
| PH12015501033A1 (en) | Peptides | |
| EA201491886A1 (ru) | Полипептиды профилина растений для применения в неспецифической иммунотерапии аллергии | |
| MY193724A (en) | Immune modulation | |
| EA029703B9 (ru) | Новый аллерген из пыльцы амброзии и его применение | |
| MX2020012569A (es) | Moleculas inmunoterapeuticas novedosas y sus usos. | |
| IN2014CN00547A (es) |